People
“VLPs have special immunological properties and are processed differently by the immune system so they have longer duration,” Adam Simpson, CEO of Icosavax, told BioSpace.
Although many cyber criminals have pledged not to attack healthcare providers during the COVID-19 pandemic, one expert tells CNBC that this may not extend to pharmaceutical companies.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 13, 2020.
The company plans to open a new 90,000 square foot facility this summer. It was a facility that VIVEX’s employees helped design in order to make it as efficient as possible.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 12, 2020.
The restructuring is related to the planned divestiture of Intrarosa (prasterone) and Vyleesi (bremelanotide injection) and the impact of the COVID-19 pandemic.
The government has added additional charges of conspiracy, wire fraud, and forfeiture.
A smartphone diagnostic test for COVID-19 being developed by a University of Utah researcher holds the potential for quick, accurate testing without the need for individuals to go to a healthcare facility. A prototype may be ready within two to three months.
Pharma veteran Michael Varney, Genentech’s head of Research and Development, will retire from the company at the end of July after spending 15 years with the company.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 11, 2020.
PRESS RELEASES